Publication details
Results of treatment with gefitinib ("Iressa",ZD1839) in 45 patients with advanced non-small-cell lung cancer
| Authors | |
|---|---|
| Year of publication | 2003 |
| Type | Article in Proceedings |
| Conference | Woorkbook of Iressa Clinical Experience Meeting |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | non-small-cell lung cancer; gefitinib treatment; survival rate |
| Description | Forty-five patients with non-small-cell lung cancer underwent treatment with gefitinib; 51% of them had prior radiotherapy. Treatment duration was 1 to 14 months (median, 3 months). Diseased progressed in 18 patients within 3 months, but stabilised in 27 patients for longer than 3 months. Disease-related symptoms were generally milder after gefitinib treatment. |
| Related projects: |